PATENT CLAIM ANALYSIS

Application Number: 15981752
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "464000"]

Abstract:
The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.

Claim (Index 11):
The method according to  claim 9 , wherein the bromocriptine mesylate has Dv90 of less than about 10 \u03bcm after the processing.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 93.0
- Lexical Diversity: 1.25926
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14920123', '14088269', '13460452', '13773500', '15286826']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8336719385972419
- 35 USC 102 Novelty (BERT): 0.6589836464347127
- Combined Prediction Score: 0.8162031093809891
- Mean Citation Score: 658.5826119999998
- Max Citation Score: 664.2355
- Similarity Product: 606.0657369174958

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test